Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:
Medical Device

People Briefs: InVivo Therapeutics CEO Resigns; CVPath Institute, Harvard Bioscience Appoint New CEOs

This article was originally published in The Gray Sheet

  • News

Executive Summary

InVivo Therapeutics Holdings Corp. chairman and CEO resigns. CVPath Institute and Harvard Bioscience get new CEOs. Cook Medical appoints VP to lead its aortic intervention clinical division. Sunshine Heart names chief medical officer.

You may also be interested in...



People In Brief

Edwards Lifesciences chief financial officer to retire. Trice Orthopedics raises $3 million, names president. More people briefs

News In Brief

Merit snaps up Thomas Medical. Halma buys MicroSurgical Technology. Sanofi settles Hyalgan charges. More news briefs.

Sunshine Heart Gears Up For Heart Failure Implant Pivotal Trial

Firm preps for U.S. pivotal trial and European market launch in the third quarter for its minimally invasive, extra-aortic balloon counter-pulsation system for moderate to severe heart failure.

Table

View full table

Related Content

Medtech Insight

Topics

Tags:
Medical Device
Latest Headlines

News We’re Watching: Free COVID-19 Tests, Edwards Antitrust Investigation, McKinsey Calls For Medtech ‘Reinvention’

Proposed Rule Would Apply FDA’s Diagnostic Rules To LDTs

Four More Guidance Documents Released: Antimicrobial Devices, Closed-Loop Control Technology, De Novo Submissions, Devices For Graft Versus Host Diseases

Minute Insight: SpectralMD Signs Another Contract With BARDA, Worth $149m

See All
UsernamePublicRestriction

Register

MT032377

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By